Chronic pruritus associated with dermatologic disease in infancy and childhood: Update from an interdisciplinary group of dermatologists and pediatricians

Pediatric Allergy and Immunology

Volumn 24, Issue 6, 2013, Pages 527-539

  Metz, Martin ^a   Wahn, Ulrich ^a   Gieler, Uwe ^b   Stock, Philippe ^a   Schmitt, Jochen ^c   Blume Peytavi, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Atopic dermatitis; Chronic spontaneous urticaria; Multidisciplinary management; Pediatric; Pruritus; Quality of life

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPRURITIC AGENT; CALCINEURIN INHIBITOR; CAPSAICIN; CATHEPSIN S; CORTICOSTEROID; CYCLOSPORIN A; CYSTEINE; DOXEPIN; GAMMA INTERFERON; GASTRIN RELEASING PEPTIDE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; INTERLEUKIN 31; MACROLIDE; METHYLPREDNISOLONE ACEPONATE; MU OPIATE RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NALTREXONE; NEUROPEPTIDE; OMALIZUMAB; PIMECROLIMUS; PROSTAGLANDIN; PROTEINASE; SUBSTANCE P; TACROLIMUS; UNINDEXED DRUG; ZAFIRLUKAST;

5 D ITCH SCALE; ARTICLE; ATOPIC DERMATITIS; BEHAVIOR THERAPY; CHILD; CHILD DERMATOLOGY LIFE QUALITY INDEX; CHILD HEALTH CARE; CHILDHOOD; CHILDHOOD ATOPIC DERMATITIS IMPACT SCALE; CHILDHOOD DISEASE; CHILDREN DERMATOLOGY LIFE QUALITY INDEX; CHOLESTASIS; CHRONIC DISEASE; CHRONIC PRURITUS; CHRONIC SPONTANEOUS URTICARIA; CONSENSUS DEVELOPMENT; DERMATITIS FAMILY IMPACT QUESTIONNAIRE; DERMATOLOGIST; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECZEMA AREA AND SEVERITY INDEX; EMOTION; EPPENDORF ITCH QUESTIONNAIRE; FAMILY HISTORY; HEALTH CARE NEED; HODGKIN DISEASE; HUMAN; INFANCY; INFANT; INFANT DERMATOLOGY LIFE QUALITY INDEX; INFLAMMATION; ITCH SEVERITY SCALE; KIDNEY DISEASE; MENTAL DISEASE; MENTAL STRESS; NEUROANATOMY; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; NUMERICAL RATIO SCALE; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT ORIENTED ECZEMA MEASURE; PEDIATRICIAN; PHOTOTHERAPY; POLYCYTHEMIA VERA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PSYCHOSOCIAL CARE; PUVA; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELAXATION TRAINING; RENAL REPLACEMENT THERAPY; SCORING OF ATOPIC DERMATITIS SCALE; SCORING SYSTEM; SKIN CARE; SKIN DISEASE; SKIN EXAMINATION; SKIN NERVE; SKINDEX 16; SKINDEX TEEN; SPINAL GANGLION; STRESS MANAGEMENT; TOPICAL TREATMENT; URTICARIA; URTICARIA ACTIVITY SCORE; VERBAL RATING SCALE; VISUAL ANALOG SCALE; XEROSIS;

ATOPIC DERMATITIS; CHRONIC SPONTANEOUS URTICARIA; MULTIDISCIPLINARY MANAGEMENT; PEDIATRIC; PRURITUS; QUALITY OF LIFE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CONSENSUS; DERMATITIS, ATOPIC; DERMATOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; INFANT; INTERDISCIPLINARY COMMUNICATION; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; PRURITUS; QUALITY OF LIFE;

EID: 84883176184     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12115     Document Type: Article

References (138)

1. Weisshaar E, Szepietowski JC, Darsow U, et al. European guideline on chronic pruritus. Acta Derm Venereol 2012: 92: 563-8.
2. Weisshaar E, Diepgen TL, Luger TA, Seeliger S, Witteler R, Stander S. Pruritus in pregnancy and childhood-do we really consider all relevant differential diagnoses? Eur J Dermatol 2005: 15: 320-31.
3. Stander S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007: 87: 291-4.
4. Metz M, Stander S. Chronic pruritus-pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2010: 24: 1249-60.
5. Metz M, Ständer S. Chronic pruritus. CME Dermatol 2008: 3(3): 124-43. published 30.11.08 www.akademos.de/derma
6. Stander S. Chronic pruritus: principals of diagnostics and therapy. Hautarzt 2007: 58: 627-36; quiz 37.
7. Matterne U, Apfelbacher CJ, Loerbroks A, et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 2011: 91: 674-9.
8. Valet M, Pfab F, Sprenger T, et al. Cerebral processing of histamine-induced itch using short-term alternating temperature modulation-an FMRI study. J Invest Dermatol 2008: 128: 426-33.
9. Bandell M, Patapoutian A. Itching for insight. Cell 2009: 139: 1224-6.
10. Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 2010: 65: 805-21.
11. Yosipovitch G. Recent advances in pruritus - what we have learned and where are we headed. F1000 Med Rep 2010: 2. pii: 39. doi: 10.3410/M2-39.
12. Davidson S, Giesler GJ. The multiple pathways for itch and their interactions with pain. Trends Neurosci 2010: 33: 550-8.
13. Ishiuji Y, Coghill RC, Patel TS, Oshiro Y, Kraft RA, Yosipovitch G. Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 2009: 161: 1072-80.
14. Asero R, Tedeschi A. AAITO position paper. Pruritus: causes, diagnostic workup and treatment. Eur Ann Allergy Clin Immunol 2007: 39: 221-4.
15. Sabin BR, Peters N, Peters AT. Atopic dermatitis. Allergy Asthma Proc 2012: 33 (Suppl. 1): 67-9.
16. Ruggiero G, Gelmetti C, Adamo MC, et al. Atopic dermatitis (AD) management in an Italian pediatric clinic. G Ital Dermatol Venereol 2012: 147: 71-81.
17. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006: 368: 733-43.
18. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008: 121: 947-54 e15.
19. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994: 30: 35-9.
20. Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010: 24: 317-28.
21. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980: 92: 44-7.
22. Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007: 120: 1389-98.
23. Schmitt J, Langan S, Stamm T, Williams HC. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol 2011: 131: 623-30.
24. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997: 195: 10-9.
25. Herguner S, Kilic G, Karakoc S, Tamay Z, Tuzun U, Guler N. Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria. Br J Dermatol 2011: 164: 1342-7.
26. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997: 136: 197-201.
27. Greaves MW. Chronic urticaria in childhood. Allergy 2000: 55: 309-20.
28. Church MK, Weller K, Stock P, Maurer M. Chronic spontaneous urticaria in children: itching for insight. Pediatr Allergy Immunol 2011: 22: 1-8.
29. Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 2011: 66: 317-30.
30. Gaig P, Olona M, Munoz Lejarazu D, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004: 14: 214-20.
31. Bailey E, Shaker M. An update on childhood urticaria and angioedema. Curr Opin Pediatr 2008: 20: 425-30.
32. Novembre E, Cianferoni A, Mori F, et al. Urticaria and urticaria related skin condition/disease in children. Eur Ann Allergy Clin Immunol 2008: 40: 5-13.
33. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009: 64: 1417-26.
34. Ehlers I, Niggemann B, Binder C, Zuberbier T. Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy 1998: 53: 1074-7.
35. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008: 63: 777-80.
36. Wahlgren CF. Children's rating of itch: an experimental study. Pediatr Dermatol 2005: 22: 97-101.
37. Bartoshuk LM, Duffy VB, Green BG, et al. Valid across-group comparisons with labeled scales: the gLMS versus magnitude matching. Physiol Behav 2004: 82: 109-14.
38. Langner MD, Maibach HI. Pruritus measurement and treatment. Clin Exp Dermatol 2009: 34: 285-8.
39. Majeski CJ, Johnson JA, Davison SN, Lauzon CJ. Itch Severity Scale: a self-report instrument for the measurement of pruritus severity. Br J Dermatol 2007: 156: 667-73.
40. Darsow U, Scharein E, Simon D, Walter G, Bromm B, Ring J. New aspects of itch pathophysiology: component analysis of atopic itch using the 'Eppendorf Itch Questionnaire'. Int Arch Allergy Immunol 2001: 124: 326-31.
41. Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol 2010: 162: 587-93.
42. Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012: 67: 99-106.
43. Weisshaar E, Gieler U, Kupfer J, Furue M, Saeki H, Yosipovitch G. Questionnaires to assess chronic itch: a consensus paper of the special interest group of the International Forum on the Study of Itch. Acta Derm Venereol 2012: 92: 493-6.
44. Tey HL, Yosipovitch G. Report on the 6th World Congress of Itch. J Invest Dermatol 2012: 132: 1065-7.
45. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001: 5: 105-10.
46. Smidt AC, Lai JS, Cella D, Patel S, Mancini AJ, Chamlin SL. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol 2010: 146: 865-9.
47. Chamlin SL, Cella D, Frieden IJ, et al. Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol 2005: 125: 1106-11.
48. Lewis-Jones S. Atopic dermatitis in childhood. Hosp Med 2001: 62: 136-43.
49. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995: 132: 942-9.
50. Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol 2008: 59: 234-44.
51. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol 1998: 138: 107-13.
52. Baiardini I, Giardini A, Pasquali M, et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003: 58: 621-3.
53. Maurer M, Ortonne JP, Zuberbier T. Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients. Br J Dermatol 2009: 160: 633-41.
54. Mlynek A, Magerl M, Hanna M, et al. The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009: 64: 927-36.
55. Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006: 154: 294-8.
56. Schmitt J, Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012: 67: 1111-7.
57. Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010: 64: 269-73.
58. Schmitt J, Apfelbacher C, Chen CM, et al. Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 2010: 125: 404-10.
59. Schmitt J, Chen CM, Apfelbacher C, et al. Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus. Allergy 2011: 66: 404-11.
60. Schmitt J, Romanos M, Schmitt NM, Meurer M, Kirch W. Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 2009: 301: 724-6.
61. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005: 22: 192-9.
62. Chamlin SL. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther 2006: 19: 104-7.
63. Chamlin SL, Frieden IJ, Williams ML, Chren MM. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004: 114: 607-11.
64. Schmitt J, Romanos M, Pfennig A, Leopold K, Meurer M. Psychiatric comorbidity in adult eczema. Br J Dermatol 2009: 161: 878-83.
65. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997: 76: 159-62.
66. Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: who cares? Who pays? J Am Acad Dermatol 1993: 28: 699-703.
67. Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergologica 2005. J Investig Allergol Clin Immunol 2009: 19 (Suppl. 2): 21-6.
68. Powell RJ, Du Toit GL, Siddique N, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007: 37: 631-50.
69. Bender BG, Ballard R, Canono B, Murphy JR, Leung DY. Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol 2008: 58: 415-20.
70. Bender BG, Leung SB, Leung DY. Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure. J Allergy Clin Immunol 2003: 111: 598-602.
71. Chamlin SL, Mattson CL, Frieden IJ, et al. The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med 2005: 159: 745-50.
72. Stores G, Burrows A, Crawford C. Physiological sleep disturbance in children with atopic dermatitis: a case control study. Pediatr Dermatol 1998: 15: 264-8.
73. Smaldone A, Honig JC, Byrne MW. Sleepless in America: inadequate sleep and relationships to health and well-being of our nation's children. Pediatrics 2007: 119 (Suppl. 1): S29-37.
74. Alanne S, Nermes M, Soderlund R, Laitinen K. Quality of life in infants with atopic dermatitis and healthy infants: a follow-up from birth to 24 months. Acta Paediatr 2011: 100: e65-70.
75. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, Sampson HA, Lupo M. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995: 149: 856-60.
76. Reuveni H, Chapnick G, Tal A, Tarasiuk A. Sleep fragmentation in children with atopic dermatitis. Arch Pediatr Adolesc Med 1999: 153: 249-53.
77. Kini SP, DeLong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol 2011: 147: 1153-6.
78. Finlay AY. Practice gaps. Dermatologists should better integrate quality-of-life measures to inform and improve clinical decision making: comment on "The impact of pruritus on quality of life". Arch Dermatol 2011: 147: 1157.
79. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy 2000: 55: 240-5.
80. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am 2010: 30: 269-80.
81. Burgess JA, Lowe AJ, Matheson MC, Varigos G, Abramson MJ, Dharmage SC. Does eczema lead to asthma? J Asthma 2009: 46: 429-36.
82. Gordon BR. The allergic march: can we prevent allergies and asthma? Otolaryngol Clin North Am 2011: 44: 765-77, xi.
83. Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004: 113: 925-31.
84. Kapoor R, Menon C, Hoffstad O, Bilker W, Leclerc P, Margolis DJ. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008: 58: 68-73.
85. Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999: 103: 1173-9.
86. Lowe AJ, Carlin JB, Bennett CM, et al. Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol 2008: 121: 1190-5.
87. Martin PE, Matheson MC, Gurrin L, et al. Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades. J Allergy Clin Immunol 2011: 127: 1473-9 e1.
88. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995: 332: 133-8.
89. Ohshima Y, Yamada A, Hiraoka M, et al. Early sensitization to house dust mite is a major risk factor for subsequent development of bronchial asthma in Japanese infants with atopic dermatitis: results of a 4-year followup study. Ann Allergy Asthma Immunol 2002: 89: 265-70.
90. Ricci G, Patrizi A, Baldi E, Menna G, Tabanelli M, Masi M. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases. J Am Acad Dermatol 2006: 55: 765-71.
91. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010: 105: 99-106; quiz 07-9, 17.
92. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003: 112: S118-27.
93. Darsow U, Pfab F, Valet M, et al. Pruritus and atopic dermatitis. Clin Rev Allergy Immunol 2011: 41: 237-44.
94. Simons FE. Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol 2001: 107: 703-6.
95. Charlesworth EN, Beltrani VS. Pruritic dermatoses: overview of etiology and therapy. Am J Med 2002: 113 (Suppl. 9A): 25S-33S.
96. Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I. J Eur Acad Dermatol Venereol 2012: 26: 1045-60.
97. Sher LG, Chang J, Patel IB, Balkrishnan R, Fleischer AB Jr. Relieving the pruritus of atopic dermatitis: a meta-analysis. Acta Derm Venereol 2012: 92: 455-61.
98. Johanek LM, Meyer RA, Friedman RM, et al. A role for polymodal C-fiber afferents in nonhistaminergic itch. J Neurosci 2008: 28: 7659-69.
99. Papoiu AD, Tey HL, Coghill RC, Wang H, Yosipovitch G. Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch. PLoS ONE 2011: 6: e17786.
100. Papoiu AD, Coghill RC, Kraft RA, Wang H, Yosipovitch G. A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. Neuroimage 2012: 59: 3611-23.
101. West DP, Worobec S, Solomon LM. Pharmacology and toxicology of infant skin. J Invest Dermatol 1981: 76: 147-50.
102. Turpeinen M. Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children. Br J Dermatol 1988: 118: 517-22.
103. Blume-Peytavi U, Wahn U. Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. J Eur Acad Dermatol Venereol 2011: 25: 508-15.
104. Fleischer AB Jr, Boguniewicz M. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature. J Drugs Dermatol 2010: 9: 488-98.
105. Curto L, Camero LI, Lopez D, Traveria G, Roura G, Giménez-Arnau A. Fast relief of pruritus using methylprednisolone aceponate to treat nickel sulfate induced eczema. Abstract NIMPA PRA12-1058. Presented at 21st EADV Congress in Prague, Czech Republic, 27-30 September, 2012.
106. Abramovits W. Atopic dermatitis. J Am Acad Dermatol 2005: 53: S86-93.
107. Hashizume H, Takigawa M. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2006: 6: 335-9.
108. Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 2001: 70: 6-16.
109. Halvorsen JA, Dalgard F, Thoresen M, Bjertness E, Lien L. Itch and Pain in Adolescents are Associated with Suicidal Ideation. A Population-based Cross-sectional Study: Acta Derm Venereol 2012: 92(5): 543-6.
110. Kimata H. Prevalence of suicidal ideation in patients with atopic dermatitis. Suicide Life Threat Behav 2006: 36: 120-4.
111. Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, Wright IM. Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. J Clin Endocrinol Metab 2003: 88: 5427-32.
112. Donelan J, Boucher W, Papadopoulou N, et al. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 2006: 103: 7759-64.
113. Staab D, Diepgen TL, Fartasch M, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006: 332: 933-8.
114. Rosenbaum MS, Ayllon T. The behavioral treatment of neurodermatitis through habit-reversal. Behav Res Ther 1981: 19: 313-8.
115. Staab D, von Rueden U, Kehrt R, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002: 13: 84-90.
116. Stangier U, Ehlers A, Gieler U. Predicting long-term outcome in group treatment of atopic dermatitis. Psychother Psychosom 2004: 73: 293-301.
117. Weisshaar E, Diepgen TL, Bruckner T, et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol 2008: 88: 234-9.
118. Chida Y, Steptoe A, Hirakawa N, Sudo N, Kubo C. The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol 2007: 144: 1-9.
119. de Bes J, Legierse CM, Prinsen CA, de Korte J. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol 2011: 91: 12-7.
120. Gelmetti C, Boralevi F, Seite S, et al. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient. Pediatr Dermatol 2012: 29: 714-8.
121. Chavigny JM, Adiceom F, Bernier C, Debons M, Stalder JF. Assessment of an educational program in an "Atopic School": pilot study in 40 patient. Ann Dermatol Venereol 2002: 129: 1003-7.
122. Ersser SJ, Latter S, Sibley A, Satherley PA, Welbourne S. Psychological and educational interventions for atopic eczema in children. Cochrane Database of Systematic Reviews 2007: issue 3. Art. No.: CD004054. DOI: 10.1002/14651858.CD004054.pub2.
123. Futamura M, Ito K, Otsuji K, et al. Effects of "Skin Care School", a parental education program on childhood atopic dermatitis conducted during short hospitalization stays. Arerugi 2009: 58: 1610-8.
124. Kupfer J, Gieler U, Diepgen TL, et al. Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial. J Psychosom Res 2010: 68: 353-8.
125. Lambert J, Bostoen J, Geusens B, et al. A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results. Arch Dermatol Res 2011: 303: 57-63.
126. Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol 2009: 50: 100-6.
127. Ricci G, Bendandi B, Aiazzi R, Patrizi A, Masi M. Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis. Pediatr Dermatol 2009: 26: 1-5.
128. Barbarot S, Gagnayre R, Bernier C, et al. A guide for education programs in atopic dermatitis. Ann Dermatol Venereol 2007: 134: 121-7.
129. Schuttelaar ML, Vermeulen KM, Drukker N, Coenraads PJ. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol 2010: 162: 162-70.
130. Stander S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002: 11: 12-24.
131. Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol 1994: 31: 613-6.
132. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995: 131: 1403-8.
133. Brune A, Metze D, Luger TA, Stander S. Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients. Hautarzt 2004: 55: 1130-6.
134. Ballester I, Silvestre JF, Perez-Crespo M, Lucas A. Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients. Actas Dermosifiliogr 2009: 100: 883-7.
135. Heller M, Shin HT, Orlow SJ, Schaffer JV. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol 2007: 157: 127-32.
136. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006: 118: 152-69.
137. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009: 64: 1427-43.
138. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 2006: 86: 1309-79.